UNSPSC 85502956: Supplement right common carotid artery with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right common carotid artery with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 03UH3KZ

UNSPSC 85502956 Supplement right common carotid artery with nonautologous tissue substitute, percutaneous approach (Commodity) shows no meaningful state and local procurement activity aligned with its nominal scope. The code appears to describe a specific surgical procedure code derived from clinical or medical device taxonomy, not a procurement category. Recent opportunities tagged under this code span unrelated services including independent medical evaluation administration, pharmacy benefit management, occupational medical surveillance, and temporary health professional staffing — none of which involve vascular surgery, tissue substitutes, or the procedural intervention the code nominally describes. The mismatch suggests either a data-entry error in code assignment or a fundamental misalignment between the UNSPSC taxonomy and how the source opportunities were categorized.

The only solicitations present are administrative and staffing services rather than medical devices or surgical supplies. The City of Phoenix Retirement Office sought independent medical evaluation services for disability determinations (RFP RTMRFP26001, due October 16, 2026); the City of Long Beach requested proposals for a surgical procedure carve-out benefit program administering Centers of Excellence networks (RFP HR26753, due October 7, 2026); and the County of Santa Clara Health System established a qualified vendor pool for temporary health professional staffing across thirteen ancillary clinical categories (RFSQ HHSFY270052, due October 7, 2026). No opportunity in the source procurement record involves procurement of the vascular supplement, surgical implants, or procedural medical devices this commodity code nominally represents. The code warrants close review for coding accuracy before pursuing.